RPL Peptide
Official Technical Documentation
Safety Data Sheet
Safety Data Sheet — Retatrutide (Lyophilized)¶
SECTION 1: Identification¶
| Field | Detail |
|---|---|
| Product Name | Retatrutide (Lyophilized Research Peptide) |
| Chemical Family | Synthetic Peptide / Biochemical Research Reagent |
| CAS Number | 2381089-83-2 |
| Supplier | RPL Peptide (Qingdao RPL Biotechnology Co., Ltd.) |
| Address | Qingdao, Shandong Province, China |
| Website | www.rplpeptides.com |
| Intended Use | Laboratory research use only |
SECTION 2: Hazards Identification¶
GHS Classification: Not classified as hazardous in solid form under normal handling conditions.
Potential Hazards: - Dust/aerosol may cause respiratory irritation if inhaled - May cause eye irritation upon direct contact - Avoid ingestion - Lyophilized peptide may be hygroscopic
SECTION 3: Composition / Information on Ingredients¶
| Component | Details |
|---|---|
| Active Ingredient | Retatrutide (≥99.0% pure) |
| Counterion | TFA (CAS 76-05-1) — residual (<1%) |
| Water | Residual moisture (<5%) |
| Excipients | Mannitol or sucrose may be present (variable) |
SECTION 4: First-Aid Measures¶
| Route | Procedure |
|---|---|
| Inhalation | Move to fresh air. Seek medical attention if breathing difficulty persists. |
| Skin Contact | Wash with soap and water for 15 minutes. |
| Eye Contact | Rinse with water for 15 minutes. Seek medical attention if irritation persists. |
| Ingestion | Rinse mouth. Do NOT induce vomiting. Seek immediate medical attention. |
SECTION 5: Fire-Fighting Measures¶
Extinguishing Media: Water spray, dry chemical, CO₂, alcohol-resistant foam. Thermal Decomposition: CO, CO₂, NOx, HF.
SECTION 6–11: Standard Safety Information¶
(Refer to the Tirzepatide SDS for full 16-section GHS structure — generic lyophilized peptide safety profile applies.)
SECTION 14: Transport Information¶
| Classification | Detail |
|---|---|
| UN Number | Not regulated |
| Hazard Class | Not classified as hazardous goods |
This SDS is for informational purposes. Users should conduct their own risk assessment.
© 2026 RPL Peptide
Official Technical Documentation
rplpeptides.com